{"analyses":[{"ciPctValue":"95","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.001","statisticalMethod":"t-test, 2 sided","testedNonInferiority":false}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"6.7","value":"17.3"},{"groupId":"OG001","spread":"4.2","value":"13.5"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"42"}],"units":"Participants"}],"description":"Mean survey response at 90 days post surgery between the control patients and the endonasal surgery patients using the Anterior skull base nasal inventory (ASK Nasal Inventory. A 5-point Likert scale for each question on the ASK Nasal inventory measures frequency of nasal symptoms where 1=never, 2= a little of the time, 3=some of the time, 4=most of the time, 5= all of the time. Total mean Likert scores were compared in the endonasal group to the control group after surgery. Scores range from minimum of 9 to maximum of 45. The lower the score the fewer the nasal complaints.","dispersionType":"Standard Deviation","groups":[{"description":"Patients undergoing endonasal surgery for anterior skull base tumors, pituitary tumors, and skull base spinal fluid leaks using endonasal techniques.","id":"OG000","title":"Endonasal Group"},{"description":"Patients undergoing any neurosurgical procedure requiring general anesthesia that did not involve the endonasal corridor, such as spinal decompression procedures, craniotomies for trigeminal neuralgia, or shunting procedures.","id":"OG001","title":"Control Group"}],"paramType":"MEAN","populationDescription":"Power analyses were conducted to determine a sample size large enough to significantly detect change with 90% power using a pre- post research methodology.","reportingStatus":"POSTED","timeFrame":"Baseline, 90 days post surgery","title":"Change in Mean Survey Response From Baseline to 90 Days Post Surgery","type":"PRIMARY","unitOfMeasure":"units on a scale"}